GHRP-6 Hilma Biocare

GHRP-6 by Hilma Biocare, also known as Pralmorelin, is a high-purity growth hormone releasing peptide engineered to trigger a powerful natural spike in growth hormone. By activating ghrelin receptors and the pituitary GH pathway, it creates an amplified anabolic environment that supports faster muscle growth, better recovery and more efficient fat loss. It is especially valued during bulking phases for its strong appetite-stimulating effect, which makes hitting a calorie surplus far easier. Each vial is supplied as lyophilized powder for reconstitution.
| Active substance | GHRP-6 (Pralmorelin) |
| Manufacturer | Hilma Biocare |
| Form | Lyophilized powder for reconstitution |
| Typical dosage | 100–300 mcg, 1–3× daily |
| Class | GH secretagogue (GHRP) |
| Focus | Bulking, recovery, appetite |
Effects and benefits
GHRP-6 drives a strong pulse of growth hormone that supports lean tissue growth and repair. Its pronounced hunger effect is the strongest of the common GHRPs, making it a go-to choice for hard-gainers who struggle to eat enough during a mass phase.
- Powerful natural GH release
- Supports muscle growth and recovery
- Very strong appetite stimulation
- Improves fat-loss efficiency over time
Usage and administration
GHRP-6 is reconstituted with bacteriostatic water and dosed around 100–300 mcg one to three times daily, ideally on an empty stomach around training and before sleep. As a research peptide it belongs alongside the rest of the peptides range rather than in an anabolic cycle.
Stacking and combinations
For a stronger, more sustained release, GHRP-6 is commonly paired with a GHRH like CJC-1295 DAC, while GHRP-2 is a close alternative with a slightly milder appetite response.
Why choose Hilma Biocare
Each vial is produced to consistent pharmaceutical standards with reliable peptide content you can trust. Explore the full Hilma Biocare catalogue to build a complete GH-support stack.
| Characteristics | |
| Shelf Life | 36 months from manufacture date |
| Drug Class | Growth Hormone Releasing Peptide |
| Concentration | Typically 5 mg per vial |
| Half-Life | Approximately 15-60 minutes |
| Detection Time | Not typically tested in standard drug screenings |
| Active Substance | GHRP-6 |
| Dosage | 100-300 mcg 2-3 times daily |
| Drug Category | Peptide |
| Form | Lyophilized powder |
| Product Packaging | 10 mg vial |
| Liver Toxicity | None |
| Chemical Structure | C46H56N12O6 |
